Cleavage stimulation factor 2 promotes malignant progression of liver hepatocellular carcinoma by activating phosphatidylinositol 3′-kinase/protein kinase B/mammalian target of rapamycin pathway-Reference-Cited by-同舟云学术

Cleavage stimulation factor 2 promotes malignant progression of liver hepatocellular carcinoma by activating phosphatidylinositol 3′-kinase/protein kinase B/mammalian target of rapamycin pathway

Published:2022-04-01 Issue:4 Volume:13 Page:10047-10060
ISSN:2165-5979
Container-title:Bioengineered
language:en
Short-container-title:Bioengineered

Author:

Zhang Meng-Hui¹²,Liu Jun¹^ORCID

Affiliation:

1. Department of Hepatobiliary Surgery and Center of Organ Transplantation, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, People’s Republic of China

2. Department of General Surgery, The Fourth People’s Hospital of Jinan, Jinan, Shandong, People’s Republic of China

Funder

funding

Publisher

Informa UK Limited

Subject

Applied Microbiology and Biotechnology,General Medicine,Bioengineering,Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21655979.2022.2063100

Reference37 articles.

1. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020

2. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries